Your browser doesn't support javascript.
loading
Efficacy and safety of a smartphone application-based treatment of ketogenic diet in pediatric refractory epilepsy.
Li, Wei; Gu, Wei; Liang, Chao; Tu, Fulai; Ding, Le; Lu, Xiaopeng; Guo, Hu; Zheng, Guo; Wu, Chunfeng.
Affiliation
  • Li W; Department of Clinical Research Center, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Gu W; Department of Clinical Research Center, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Liang C; Department of Neurology, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Tu F; Key Laboratory of Environmental Medicine Engineering, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, China.
  • Ding L; Department of Neurology, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Lu X; Department of Neurology, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Guo H; Department of Neurology, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Zheng G; Department of Neurology, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Wu C; Department of Neurology, Children's Hospital of Nanjing Medical University, Nanjing, China.
Epilepsia Open ; 9(1): 278-286, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37969060
ABSTRACT

OBJECTIVE:

We aimed to find predictors for smartphone application-based ketogenic diet (KD) treatment effectiveness and safety.

METHODS:

The efficacy was evaluated according to the reduction in seizure frequency after the intervention of KD; safety was evaluated based on adverse effects. The ordinal logistic regression analysis was used to explore the influencing factors of efficacy.

RESULTS:

The study sample included 116 males and 65 females with a median age of 2.27 years. The baseline frequency of seizure was more than five times/day in 123 children, 50.83% of them received three or more antiepileptic drugs (AEDs). Seventy-two patients' KD initiation mode was outpatient, and 73 completed the 12-month follow-up. A total of 88 (48.62%) patients had reported a reduction in seizure ≥50%. Compared with 12 months, those who had received KD therapy for only 3 (P = 0.009) and 6 months (P = 0.005) were more likely to show negative outcomes. Outpatient initiation had better outcomes (P = 0.029) than inpatient initiation. For the number of AEDs applied, patients on two AEDs were more likely to achieve better outcomes (P = 0.001). Adverse events had been noted among 77 patients; BMI Z-score at KD initiation was associated with adverse effects (P = 0.003).

SIGNIFICANCE:

Our study suggested that outpatient initiation and long-term treatment of KD should be encouraged. PLAIN LANGUAGE

SUMMARY:

Our research shows that the KD is a helpful treatment for children with refractory epilepsy, reducing seizures by more than 50% in nearly half of the cases, with some experiencing complete seizure freedom. We used a smartphone app to improve communication between patients and their healthcare teams, resulting in a high retention, and app usage was linked to reduced adverse effects. We recommend early consideration of KD treatment for patients failing two AED, encourage outpatient initiation, and advocate for longer-term KD use.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diet, Ketogenic / Mobile Applications / Drug Resistant Epilepsy Limits: Child / Child, preschool / Female / Humans / Male Language: En Journal: Epilepsia Open Year: 2024 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diet, Ketogenic / Mobile Applications / Drug Resistant Epilepsy Limits: Child / Child, preschool / Female / Humans / Male Language: En Journal: Epilepsia Open Year: 2024 Document type: Article Affiliation country: China